Literature DB >> 17293087

Does in vitro fluoroquinolone resistance predict clinical failure in urinary tract infections?

Loren G Miller, Rajnish Mehrotra, Angela W Tang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17293087     DOI： 10.1016/j.ijantimicag.2006.11.021

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  5 in total

1.  Urinary tract infection in primary care.

Authors:  Dee Mangin; Les Toop
Journal:  BMJ       Date:  2007-03-24

Review 2.  The role of fluoroquinolones in the management of urinary tract infections in areas with high rates of fluoroquinolone-resistant uropathogens.

Authors:  Y-H Chen; W-C Ko; P-R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

3.  Urinary Tract Physiological Conditions Promote Ciprofloxacin Resistance in Low-Level-Quinolone-Resistant Escherichia coli.

Authors:  Guillermo Martín-Gutiérrez; Jerónimo Rodríguez-Beltrán; José Manuel Rodríguez-Martínez; Coloma Costas; Javier Aznar; Álvaro Pascual; Jesús Blázquez
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

Review 4.  Contemporary management of uncomplicated urinary tract infections.

Authors:  David R P Guay
Journal:  Drugs       Date:  2008       Impact factor: 9.546

5.  Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L.

Authors:  Yeonjae Kim; Bongyoung Kim; Seong Heon Wie; Jieun Kim; Moran Ki; Yong Kyun Cho; Seung Kwan Lim; Jin Seo Lee; Ki Tae Kwon; Hyuck Lee; Hee Jin Cheong; Dae Won Park; Seong Yeol Ryu; Moon Hyun Chung; Hyunjoo Pai
Journal:  Antibiotics (Basel)       Date:  2021-01-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.